Table 1.
Incidences of cancer and precancerous lesions.
| n | Liver | Gastric | Kidney | ||||
|---|---|---|---|---|---|---|---|
| Cancer (%) | Pre-cancer (%) | Cancer (%) | Pre-cancer (%) | Cancer (%) | Pre-cancer (%) | ||
| Control group | 20 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Benzo(GHI)perylene 5 mg/kg | 19 | 4 (21.1) | 13 (68.4) | 4 (21.1) | 15 (78.9) | 0 (0.0) | 8 (42.1) |
| Benzo(a)pyrene 10 mg/kg | 19 | 5 (26.3) | 14 (73.7) | 0 (0.0) | 13 (68.4) | 0 (0.0) | 9 (47.4) |
| Benzo(a)pyrene 20 mg/kg | 17 | 6 (35.3) | 11 (64.7) | 7 (41.2) | 5 (29.4) | 2 (11.8) | 10 (58.8) |
| Anthracene 50 mg/kg | 18 | 5 (27.8) | 10 (55.6) | 0 (0.0) | 5 (27.8) | 0 (0.0) | 6 (33.3) |